Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin(®)) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series

Registered pharmacological treatments are insufficiently effective for erectile dysfunction (ED) in around 30% of affected men. Intracavernosal injection (ICI) of ona- and abobotulinumtoxinA can reduce ED in insufficient responders. We aimed to assess the safety and effectiveness of incobotulinumtox...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliano, Francois, Denys, Pierre, Joussain, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030535/
https://www.ncbi.nlm.nih.gov/pubmed/35448895
http://dx.doi.org/10.3390/toxins14040286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030535/
https://www.ncbi.nlm.nih.gov/pubmed/35448895
http://dx.doi.org/10.3390/toxins14040286

Ejemplares similares